[Septicemia due to polyresistant Staphylococcus aureus (author's transl)]

Area of Science:

• Infectious Diseases
• Pharmacology
• Critical Care Medicine

Background:

• Polyresistant Staphylococcus aureus infections pose significant treatment challenges.
• Septicemia, particularly post-operative, requires effective antimicrobial therapy.
• Vancomycin hydrochloride is a critical antibiotic for severe Gram-positive bacterial infections.

Observation:

• A patient presented with necrotic, hemorrhagic acute pancreatitis and post-operative septicemic syndrome.
• The patient had a severe infection caused by polyresistant Staphylococcus aureus.
• Treatment involved a daily dose of two grammes of vancomycin hydrochloride.

Findings:

• The patient achieved a full recovery after one month of vancomycin hydrochloride treatment.
• Vancomycin hydrochloride demonstrated high efficacy in resolving severe Staphylococcus aureus septicemia.
• The observed dosage was 2 grammes daily, leading to a successful clinical outcome.

Implications:

• Vancomycin hydrochloride is a viable treatment option for severe infections caused by polyresistant Staphylococcus aureus.
• Careful administration (intravenous, 30 mg/kg/day) and monitoring are crucial due to potential nephrotoxicity and ototoxicity.
• Dosage adjustments in renal insufficiency and therapeutic drug monitoring are essential to mitigate side effects and ensure efficacy.